Bookbot

Cancer Immunology

Paramètres

  • 597pages
  • 21 heures de lecture

En savoir plus sur le livre

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume is focused on immunopathology of cancers. The interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field. Over the past decade, understanding of the interactions between the immune system and cancerous cells has increased markedly, leading to the development of combinatorial immunotherapeutic strategies to combat cancer. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists.

Achat du livre

Cancer Immunology, Nima Rezaei

Langue
Année de publication
2015
Reliure
(rigide),
État du livre
Très bon
Prix
171,99 €

Modes de paiement

Personne n'a encore évalué .Évaluer

Titre
Cancer Immunology
Langue
Anglais
Éditeur
Springer
Publié
2015
Format
rigide
Pages
597
ISBN10
3662440059
ISBN13
9783662440056
Séries
Description
Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume is focused on immunopathology of cancers. The interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field. Over the past decade, understanding of the interactions between the immune system and cancerous cells has increased markedly, leading to the development of combinatorial immunotherapeutic strategies to combat cancer. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists.